Q-Line BiotechNSE:QLINE -5.15%12 FCF Yield % is -4.52 as of Jun. 29, 2026. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Q-Line Biotech ranks worse than 64.05% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Q-Line Biotech's FCF Yield % or its related term are showing as below:
NSE:QLINE'
s FCF Yield % Range Over the Past 10 Years
Min: -5.2 Med: -4.85 Max: -4.39
Current: -4.52
During the past 3 years, the highest FCF Yield % of Q-Line Biotech was -4.39%. The lowest was -5.20%. And the median was -4.85%.
NSE:QLINE's FCF Yield % is ranked worse than 64.05% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs NSE:QLINE: -4.52
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Q-Line Biotech FCF Yield % Related Terms
Q-Line Biotech FCF Yield % Historical Data
* Premium members only.
The historical data trend for Q-Line Biotech's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-Line Biotech FCF Yield % Chart
Q-Line Biotech Annual Data
Trend
Mar23
Mar24
Mar25
FCF Yield %
0.00
0.00
0.00
Q-Line Biotech Semi-Annual Data
Mar23
Mar24
Mar25
FCF Yield %
0.00
0.00
0.00
NSE:QLINE vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Q-Line Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q-Line Biotech FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Q-Line Biotech's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Q-Line Biotech's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-Line Biotech (NSE:QLINE) has a FCF Yield % of -4.52 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Q-Line Biotech and its competitors. According to the industry distribution chart, Q-Line Biotech ranks #547 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 64.1%.
Is Q-Line Biotech's FCF Yield % too high?
Q-Line Biotech's current FCF Yield % is -4.52. Based on the distribution chart, Q-Line Biotech ranks #547 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Q-Line Biotech ranks #547 out of 854 companies for FCF Yield %. This places Q-Line Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current FCF Yield % is -4.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current FCF Yield % of -4.52. The current FCF Yield % is -4.52. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current FCF Yield % is -4.52 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score
Get the complete analysis for NSE:QLINE
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QLINE has been successfully added to your 